Table 1 Clinical findings for patients with SJS or TEN in the irrigation and control groups
Irrigation group (n = 21 cases) (%) | Control group (n = 18 cases) (%) | p value | |
|---|---|---|---|
Average age | 8.14 ± 5.782 years | 8.89 ± 6.133 years | NS* |
Gender (male: female) | 10:11 | 10:8 | NS |
Ocular manifestations of patients in the acute stage | pseudomembranes 21(100%) | pseudomembranes 18(100%) | NS |
symblepharon 5(23.81%) | symblepharon 4(22.22%) | NS | |
Number of patients caused by drug-taking | 20 (95.24%) | 17 (94.44%) | NS |
Associated drugs | antibacterial 8(38.10%) | antibacterial 7(36.84%) | NS |
anticonvulsants 6(28.57%) | anticonvulsants 4(21.05%) | NS | |
NSAIDsa 4(19.05%) | NSAIDsa 4(21.05%) | NS | |
other 3(14.29%) | other 4(21.05%) | NS | |
Systemic treatment types | systemic antibiotics and corticosteroids | systemic antibiotics and corticosteroids | |
Ocular treatment types in the acute stage | artificial tears, removal of pseudomembranes, lysis of symblepharon, topical antibiotics and corticosteroids drops, irrigations of lacrimal system with dexamethasone drops | artificial tears, removal of pseudomembranes, lysis of symblepharon, topical antibiotics and corticosteroids drops |